Table: Chugai Pharm 6-MTH group results (IFRS)

Chugai Pharmaceutical

24/07/2025 08:00

Jul 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2025        Jun 30, 2024     Dec 31, 2025 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              578.46              552.86                     
                   (+4.6 pct)          (-4.6 pct)                   
  Operating          273.34              258.20                     
                   (+5.9 pct)          (+22.4 pct)                  
  Pretax
  Net                194.39              186.26                     
                   (+4.4 pct)          (+18.9 pct)                  
  EPS Basic        118.13 yen          113.20 yen                   
  EPS Diluted      118.12 yen          113.19 yen                   
  Ann Div                               98.00 yen       250.00 yen  
  -Q2 Div          125.00 yen           41.00 yen                   
  -Q4 Div                               57.00 yen       125.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T